Open Data: Implications on Privacy in Healthcare Research

Abstract

The advent of open data in health care has increased healthcare innovation, with the publication of complete datasets aggregated by private and public entities that lead to efficiency through crowdsourcing working code, facilitating research into personalized medicine, and publishing reproducible data pipelines for experimental validation.
 However, there lacks an internationally recognized definition for health data governance at the scope of individual health data and open source big data, which bring about a discussion about the implications of open data on data privacy. First, healthcare data sourced directly from public healthcare systems: by whom and for what purpose is these data used for within the context of healthcare research. Second, health data from private research: the regulations needed for mutual disclosure. Third, personal user-generated health data: safeguards in a digital era needed to prevent misappropriation and abuse.
 This paper addresses the opportunities of open data in healthcare research in a digital age without transparent regulation. The consequence of open data on privacy leads to a framework of four safeguards for stakeholders: public education, operational transparency, regulation for accountability, and validation of research ethics. It also pioneers public policy direction for a balanced agenda between privacy and healthcare research.

Ethical frameworks of informed consent in the age of pediatric precision medicine

“…The ethics review board is in the position to define the components of the informed consent processes and should ensure that such processes can be readily understood by a lay audience, such as minors and their substitute decision-makers (Matrana and Campbell, 2020 ). In addition, review boards play an integral role in the long-term oversight of precision medicine trial-related data governance and privacy, as defined in the terms of consent (Chen, 2020 ). Taken together, ethics review boards also play an emergent role in precision medicine due to the marked overlap between medical therapy and clinical research studies in precision medicine.…”

A review of distributed ledger technologies application in medical systems interoperability

“…The ethical use of patient data and transparent consent processes are critical to the success of DLT applications in the healthcare industry (Chukwu & Garg, 2020). Healthcare organizations must strike a balance between data security and moral data practices (Chen, 2020).…”

“…Safe and efficient data transmission not only enhances patient care but also promotes medical research and public health initiatives (Hasselgren et al, 2020). However, due to differences in data models, communication protocols, and data formats, as well as the need for consistent data definitions and codification procedures, achieving these crucial goals is usually challenging (Chen, 2020).…”

Impact of Medical Technologies may be Predicted Using Constructed Graph Bibliometrics

“…Determining which proposed research projects are funded based on impact remains a dynamic process that involves a combination of peer review and quantitative research metrics [2,3]. The funding decision process requires transparency in the way public research funds are allocated based on peer review and metrics and can ensure reproducibility through increased use of publicly available data for responsible decision-making [4,5].…”